Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2005 | 2 |
2014 | 1 |
2015 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker?
Thromb Haemost. 2015 Jul;114(1):123-32. doi: 10.1160/TH14-11-0952. Epub 2015 May 7.
Thromb Haemost. 2015.
PMID: 25947356
F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty.
Ansani L, Marchesini J, Pestelli G, Luisi GA, Scillitani G, Longo G, Milani D, Serino ML, Tisato V, Gemmati D.
Ansani L, et al.
Int J Mol Sci. 2018 Sep 14;19(9):2766. doi: 10.3390/ijms19092766.
Int J Mol Sci. 2018.
PMID: 30223472
Free PMC article.
Item in Clipboard
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators.
Lincoff AM, et al.
JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.
JAMA. 2014.
PMID: 24682069
Clinical Trial.
Item in Clipboard
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, Cicchitelli G, McFadden EP, Merlini F, Ansani L, Guardigli G, Bettini A, Parrinello G, Boersma E, Ferrari R; STRATEGY Investigators.
Valgimigli M, et al. Among authors: ansani l.
JAMA. 2005 May 4;293(17):2109-17. doi: 10.1001/jama.293.17.2109.
JAMA. 2005.
PMID: 15870414
Clinical Trial.
Item in Clipboard
High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patients.
Valgimigli M, Percoco G, Cicchitelli G, Ferrari F, Barbieri D, Ansani L, Guardigli G, Parrinello G, Malagutti P, Soukhomovskaia O, Bettini A, Campo G, Ferrari R.
Valgimigli M, et al. Among authors: ansani l.
Cardiovasc Drugs Ther. 2004 May;18(3):225-30. doi: 10.1023/B:CARD.0000033644.91126.f7.
Cardiovasc Drugs Ther. 2004.
PMID: 15229391
Clinical Trial.
Item in Clipboard
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.
Valgimigli M, Rigolin GM, Cittanti C, Malagutti P, Curello S, Percoco G, Bugli AM, Della Porta M, Bragotti LZ, Ansani L, Mauro E, Lanfranchi A, Giganti M, Feggi L, Castoldi G, Ferrari R.
Valgimigli M, et al. Among authors: ansani l.
Eur Heart J. 2005 Sep;26(18):1838-45. doi: 10.1093/eurheartj/ehi289. Epub 2005 Apr 28.
Eur Heart J. 2005.
PMID: 15860518
Clinical Trial.
Item in Clipboard
Cite
Cite